July 24, 2014 4:56 PM ET

Biotechnology

Company Overview of Onyx Pharmaceuticals, Inc.

Executive Profile

Matthew K. Fust

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Onyx Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships
49$2,513,374
As of Fiscal Year 2012

Background

Mr. Matthew K. Fust, also known as Matt served as the Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Onyx Pharmaceuticals, Inc. since January 5, 2009. Mr. Fust served as the Chief Financial Officer of Jazz Pharmaceuticals Public Limited Company (also known as Jazz pharmaceuticals Inc.) from May 2003 to December 31, 2008, Executive Vice President from March 2008 to December 31, 2008, Principal Accounting Officer until December 31, ...

Corporate Headquarters

249 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-266-0000
Fax: 650-266-0100

Board Members Memberships

2005-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2014-Present
Director and Chairman of Audit Committee
2014-Present
Independent Director, Chairman of Audit Committee and Chairman of Nominating & Corporate Governance Committee
2014-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

BA
University of Minnesota
MBA
Stanford Graduate School of Business

Other Affiliations

Annual Compensation

Salary$467,900
Bonus$65,506
Total Annual Compensation$533,406

Stocks Options

Restricted Stock Awards$985,332
All Other Compensation$5,490
Exercised Options$23,458
Exercised Options Value$558,834
Exercisable Options$127,335
Exercisable Options Value$5,318,080
Unexercisable Options$77,107
Unexercisable Options Value$3,089,084
Total Value of Options$8,965,998
Total Number of Options$227,900

Total Compensation

Total Annual Cash Compensation$782,204
Total Short Term Compensation$533,406
Other Long Term Compensation$990,822
Total Calculated Compensation$2,513,374
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Onyx Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.